(IFM) myeloma: a phase 2 study of the Intergroupe Francophone du Myélome autologous stem cell transplantation in patients with de novo multiple Bortezomib and high-dose melphalan as conditioning regimen before
暂无分享,去创建一个
B. Pégourié | J. Mary | P. Moreau | H. Avet-Loiseau | G. Marit | C. Mathiot | J. Harousseau | C. Fruchart | M. Attal | B. Royer | L. Garderet | M. Roussel | A. Stoppa | C. Araujo | P. Lenain | C. Hulin | D. Caillot | Edouard Randriamalala | A. Huynh | C. Danho | B. Kolb